SMN2 and proximal spinal muscular atrophy: Other features such as SMN2 copy number, and age of onset of signs and symptoms may also impact clinical course [15, 16], but even as the clinical landscape of SMA evolves, the vast majority of patients will continue to experience weakness and fatigue.